Cleared Traditional

K073018 - STEREOTACTIC TARGET POSITIONER, TARGET POSITIONER FOR LEKSELL HEADRING, STEREOTACTIC COUNTERWEIGHT

K073018 is an FDA 510(k) clearance for STEREOTACTIC TARGET POSITIONER, manufactured by Brainlab AG. The device is a Class 2 Radiology device with product code IYE cleared through the Traditional 510(k) pathway after a 90-day FDA review.

K073018 · Brainlab AG · Radiology device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Jan 2008
Decision
90d
Days
Class 2
Risk

K073018 is an FDA 510(k) clearance for the STEREOTACTIC TARGET POSITIONER, TARGET POSITIONER FOR LEKSELL HEADRING, STERE.... Classified as Accelerator, Linear, Medical (product code IYE), Class II - Special Controls.

Submitted by Brainlab AG (Feldkirchen, DE). The FDA issued a Cleared decision on January 23, 2008 after a review of 90 days - within the typical 510(k) review window.

This device falls under the Radiology FDA review panel, regulated under 21 CFR 892.5050 - the FDA radiology and imaging software oversight framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Standard predicate-based submission. Standard predicate reliance. This clearance follows a standard predicate-based equivalence path within the Radiology review framework, consistent with the majority of Class II 510(k) submissions.

View all Brainlab AG devices

FDA 510(k) Submission Details - K073018

510(k) Number K073018 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received October 25, 2007
Decision Date January 23, 2008
Days to Decision 90 days
Submission Type Traditional
Review Panel Radiology (RA)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
17d faster than avg
Panel avg: 107d · This submission: 90d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

IYE Device Classification - Class 2, Special Controls

Product Code IYE Accelerator, Linear, Medical
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 892.5050
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Radiology devices follow this clearance model.

Regulatory Peers - IYE Accelerator, Linear, Medical

All 530
Devices cleared under the same product code (IYE) and FDA review panel - the closest regulatory comparables to K073018.
TRILOGY WITH EXTERNAL SYSTEM GATING INTERFACE
K081188 · Varian Medical Systems, Inc. · Jul 2008
MRI PATIENT POSITIONING DEVICES
K080072 · CIVCO Medical Instruments Co., Inc. · Jun 2008
4D INTEGRATED TREATMENT CONSOLE WITH PATIENT ACCESSORY VERIFICATION SYSTEM (PAVS)
K081036 · Varian Medical Systems, Inc. · May 2008
ARTISTE MV SA
K072485 · Siemens Medical Solutions USA, Inc. · Dec 2007
EQUAL DOSE 1.0
K073273 · Nucletron Corporation · Dec 2007
TRILOGY SYSTEM WITH RAPIDARC
K072916 · Varian Medical Systems, Inc. · Nov 2007